Clinical Trial

Community-Based Engagement to Improve Lung Cancer Screening and Outcomes: The "Our Lungs Our Health" Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The main goal of this pilot study is to understand the impact of a mobile lung cancer screening clinics in individuals from neighborhoods and communities with less access to resources in Boston, Massachusetts who are at high risk for lung cancer. A secondary goal of this pilot study is to understand how social determinants of health impact these neighborhoods and communities. Another secondary goal of this pilot study is to see if video recording of participants speaking to their future selves and sending the videos back to participants to encourage them to get lung cancer screening after one year can be administered in a mobile lung cancer screening setting. The questions this study aims to answer are: * Is mobile lung cancer screening is feasible and acceptable? * Is collecting social needs data during the mobile lung cancer screening clinics feasible? * Is creating video recordings of patients encouraging their future selves to get lung cancer screening after one year feasible? Participants will: * Complete an intake survey, providing information about their demographic, medical, and social needs information. * Undergo a shared decision-making conversation to determine whether lung cancer screening should be done. * Undergo lung cancer screening. * Undergo a debriefing conversation and fill out an acceptability survey. * Record a video speaking to their future selves about the importance of annual lung cancer screening, with the video to be sent back to them after roughly one year. * Undergo a semi-structured phone interview between four and eight weeks after lung cancer screening date.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-27.
Trial Details
NCT Number NCT06909981
Lead Sponsor Brigham and Women's Hospital
Conditions Lung Cancer Screening
Enrollment 125 participants
Start Date 2026-05-01
Primary Completion 2026-11-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-08